HeXun Biosciences has been growing earnings at an average annual rate of 53%, while the Life Sciences industry saw earnings growing at 4.4% annually. Revenues have been growing at an average rate of 33% per year. HeXun Biosciences's return on equity is 10.9%, and it has net margins of 37.7%.
Key information
53.05%
Earnings growth rate
54.85%
EPS growth rate
Life Sciences Industry Growth
5.47%
Revenue growth rate
32.99%
Return on equity
10.88%
Net Margin
37.74%
Last Earnings Update
30 Jun 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How HeXun Biosciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
TPEX:6986 Revenue, expenses and earnings (TWD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Jun 26
308
116
47
102
31 Mar 26
301
114
48
101
31 Dec 25
293
112
49
99
30 Sep 25
291
112
51
85
30 Jun 25
304
131
49
76
31 Mar 25
295
139
44
71
31 Dec 24
286
147
40
65
30 Sep 24
255
133
37
65
30 Jun 24
236
124
37
63
31 Mar 24
183
79
35
58
31 Dec 23
131
33
33
53
30 Sep 23
103
13
28
52
30 Jun 23
75
-7
23
51
31 Mar 23
62
-6
19
45
31 Dec 22
49
-5
14
39
Quality Earnings: 6986 has high quality earnings.
Growing Profit Margin: 6986's current net profit margins (37.7%) are lower than last year (43.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6986's earnings have grown significantly by 53% per year over the past 5 years.
Accelerating Growth: 6986's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 6986 had negative earnings growth (-11.4%) over the past year, making it difficult to compare to the Life Sciences industry average (21%).
Return on Equity
High ROE: 6986's Return on Equity (10.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/08/21 23:54
End of Day Share Price
2026/08/21 00:00
Earnings
2026/06/30
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
HeXun Biosciences Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.